Analyst Price Target is $28.00
▲ +5.50% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Misonix in the last 3 months. The average price target is $28.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 5.50% upside from the last price of $26.54.
Current Consensus is
The current consensus among 2 contributing investment analysts is to hold stock in Misonix. This Hold consensus rating has held steady for over two years.
Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.